Multivariate joint modeling to identify markers of growth and lung function decline that predict cystic fibrosis pulmonary exacerbation onset

• Published in: BMC pulmonary medicine Vol. 20; no. 1; p. 142
• Main Authors: Andrinopoulou, E R, Clancy, J P, Szczesniak, R D
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 19-05-2020; BioMed Central; BMC
• Subjects: Adolescent; Age; Antibiotics; Biomarkers - analysis; Body mass index; Child; Child Nutritional Physiological Phenomena; Cystic fibrosis; Cystic Fibrosis - physiopathology; Disease Progression; Dynamic prediction; Female; Functional data analysis; Humans; Longitudinal Studies; Lung - physiopathology; Lung diseases; Male; Medical monitoring; Models, Statistical; Multivariate Analysis; Multivariate longitudinal data; Nutrition; Nutritional Status; Patients; Physiological aspects; Predictions; Pulmonology; Registries; Registry analysis; Regression Analysis; Respiratory function; Respiratory Function Tests - methods; Risk assessment; Staphylococcus infections; Time-to-event; United States; Young Adult; United States; Time-to-event; Medical monitoring; Registry analysis; Functional data analysis; Multivariate longitudinal data; Dynamic prediction
• ISSN: 1471-2466; 1471-2466
• DOI: 10.1186/s12890-020-1177-z

Attenuated decreases in lung function can signal the onset of acute respiratory events known as pulmonary exacerbations (PEs) in children and adolescents with cystic fibrosis (CF). Univariate joint modeling facilitates dynamic risk prediction of PE onset and accounts for measurement error of the lung function marker. However, CF is a multi-system disease and the extent to which simultaneously modeling growth and nutrition markers improves PE predictive accuracy is unknown. Furthermore, it is unclear which routinely collected clinical indicators of growth and nutrition in early life predict PE onset in CF.
Using a longitudinal cohort of 17,100 patients aged 6-20 years (US Cystic Fibrosis Foundation Patient Registry; 2003-2015), we fit a univariate joint model of lung-function decline and PE onset and contrasted its predictive performance with a class of multivariate joint models that included combinations of growth markers as additional submodels. Outcomes were longitudinal lung function (forced expiratory volume in 1 s of % predicted), percentiles of body mass index, weight-for-age and height-for-age and PE onset. Relevant demographic/clinical covariates were included in submodels. We implemented a univariate joint model of lung function and time-to-PE and four multivariate joint models including growth outcomes.
All five joint models showed that declining lung function corresponded to slightly increased risk of PE onset (hazard ratio from univariate joint model: 0.97, P < 0.0001), and all had reasonable predictive accuracy (cross-validated area under the receiver-operator characteristic curve > 0.70). None of the growth markers alongside lung function as outcomes in multivariate joint modeling appeared to have an association with hazard of PE. Jointly modeling only lung function and PE onset yielded the most accurate (area under the receiver-operator characteristic curve = 0.75) and precise (narrowest interquartile range) predictions. Dynamic predictions were accurate across forecast horizons (0.5, 1 and 2 years) and precision improved with age.
Including growth markers via multivariate joint models did not yield gains in prediction performance, compared to a univariate joint model with lung function. Individualized dynamic predictions from joint modeling could enhance physician monitoring of CF disease progression by providing PE risk assessment over a patient's clinical course.